Dr. Evan Feinberg serves as the Co-Founder and Chief Executive Officer of Genesis Therapeutics. Having earned his doctorate in computational biophysics at Stanford University—where he developed foundational machine learning frameworks for molecular discovery—he has successfully scaled the enterprise, secured hundreds of millions in venture capital backing from prominent tier-one investors, and forged strategic platform partnerships with major global biopharmaceutical corporations.